Filtered By:
Source: Neurology
Management: Medicare

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 39 results found since Jan 2013.

Acute infection contributes to racial disparities in stroke mortality
Conclusions: Acute infection disproportionately increases the risk of stroke death for non-Hispanic blacks, independently of atrial fibrillation. Stroke incidence did not explain this finding. Acute infection appears to be one factor that contributes to the black–white disparity in stroke mortality.
Source: Neurology - March 17, 2014 Category: Neurology Authors: Levine, D. A., Langa, K. M., Rogers, M. A. M. Tags: Outcome research, All Infections, All Cerebrovascular disease/Stroke ARTICLE Source Type: research

Associations between Parkinson Disease and Stroke (S51.006)
Conclusions:Among Medicare beneficiaries, the relationships between stroke and PD were similar to those between stroke and AD. As in AD, a link may exist between cerebrovascular disease and PD.Study Supported by: Hooman Kamel was supported by grants from the NINDS (K23NS082367) and the Michael Goldberg Stroke Research Fund. Babak Navi was supported by grants from the NINDS (K23NS091395) and the Florence Gould Endowment for Discovery in Stroke.Disclosure: Dr. Kummer has nothing to disclose. Dr. Aaroe has nothing to disclose. Dr. Kamel has received personal compensation for activities with Genentech as a speaker. Dr. Kamel h...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Kummer, B., Aaroe, A., Kamel, H., Iadecola, C., Navi, B. Tags: Cerebrovascular Disease and Interventional Neurology: Stroke Prevention and Translation Source Type: research

The Incidence Of Secondary Stroke Prevention Medication Following Hospitalization For Ischemic Stroke (I2-1.006)
CONCLUSIONS:The incidence of statins and ACE-I/ARB initiation following a stroke, among older adults discharged home was low (24-35%). Reported rates of side effects of either class of medications are not high enough to account for the low observed incidence. Better understanding of why beneficiaries are not receiving SSP, namely statins and ACE-I/ARBs, within 90 days of an ischemic stroke is critical to preventing recurrent stroke.Study Supported by:UnfundedDisclosure: Dr. Blackburn has nothing to disclose. Dr. Zhao has nothing to disclose. Dr. Kilgore has nothing to disclose. Dr. Albright has received research support fr...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Blackburn, J., Zhao, H., Kilgore, M., Albright, K. Tags: New Antithrombotic Agents for Stroke Prevention Poster Presentations Source Type: research

African Americans Are Less Likely to Be Adherent to Statins After Ischemic Stroke: An Analysis of Medicare Beneficiaries Following Hospital Discharge (I2.006)
Conclusions: African Americans may not be obtaining the recurrent stroke prevention therapy provided by statins, possibly contributing to the higher rate of recurrent stroke in this population.Disclosure: Dr. Albright has nothing to disclose. Dr. Blackburn has nothing to disclose. Dr. Zhao has nothing to disclose. Dr. Beasley has nothing to disclose. Dr. Limdi has nothing to disclose. Dr. Howard has nothing to disclose. Dr. Muntner has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Albright, K., Blackburn, J., Zhao, H., Beasley, T., Limdi, N., Howard, V., Muntner, P. Tags: Stroke in the Elderly and Young: Challenges for the Next Decade Data Blitz Presentations Source Type: research

African Americans Are Less Likely to Be Adherent to Statins After Ischemic Stroke: An Analysis of Medicare Beneficiaries Following Hospital Discharge (S4.003)
Conclusions: African Americans may not be obtaining the recurrent stroke prevention therapy provided by statins, possibly contributing to the higher rate of recurrent stroke in this population.Disclosure: Dr. Albright has nothing to disclose. Dr. Blackburn has nothing to disclose. Dr. Zhao has nothing to disclose. Dr. Beasley has nothing to disclose. Dr. Limdi has nothing to disclose. Dr. Howard has nothing to disclose. Dr. Muntner has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Albright, K., Blackburn, J., Zhao, H., Beasley, T., Limdi, N., Howard, V., Muntner, P. Tags: Health Disparities and Sex Differences in Stroke Source Type: research

Racial differences in the Risk factors, Severity, Outcomes and Treatment in Acute Ischemic Stroke (P7.141)
Conclusion: Despite great disparity in both groups the outcomes were similar.Disclosure: Dr. Chauhan has nothing to disclose. Dr. Ali has nothing to disclose. Dr. Bianchi has nothing to disclose. Dr. Hinduja has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Chauhan, M. A., Ali, S., Bianchi, N., Hinduja, A. Tags: Cerebrovascular Disease and Interventional Neurology: Race, Ethnicity, and Stroke Source Type: research

Racial differences in statin adherence following hospital discharge for ischemic stroke
Conclusions: Compared with white adults, black adults were more likely to be nonadherent to statins following hospitalization for ischemic stroke.
Source: Neurology - May 8, 2017 Category: Neurology Authors: Albright, K. C., Zhao, H., Blackburn, J., Limdi, N. A., Beasley, T. M., Howard, G., Bittner, V., Howard, V. J., Muntner, P. Tags: All Cerebrovascular disease/Stroke ARTICLE Source Type: research

Differences in Payment for Inpatient Transient Ischemic Attack Care Between Stroke Center and Non-Stroke-Center Hospitals (P3.128)
Conclusions: There is a wide discrepancy in hospital charges and covered payments for TIA hospitalization. Larger for-profit hospitals with primary stroke center certification located in more affluent areas charge more for TIA hospitalization.Disclosure: Dr. He has nothing to disclose. Dr. Bulic has nothing to disclose. Dr. Kazaryan has nothing to disclose. Dr. Cen has nothing to disclose. Dr. Kim-Tenser has nothing to disclose. Dr. Kim-Tenser has nothing to disclose. Dr. Mack has nothing to disclose. Dr. Sanossian has received personal compensation for activities with Boehringer-Ingelheim Pharmaceutical Inc.
Source: Neurology - April 9, 2014 Category: Neurology Authors: He, S., Bulic, S., Kazaryan, S., Cen, S., Kim, M., Kim, M., Mack, W., Sanossian, N. Tags: Cerebrovascular Disease and Interventional Neurology: Primary and Comprehensive Stroke Centers Source Type: research

Blacks Have Higher Risk of 1-Year Recurrent Ischemic Stroke and Lower 30-day Case Mortality: An Analysis of White and Black Medicare Beneficiaries, 1999-2013 (P4.303)
Conclusions:When compared to whites, the risk of recurrent stroke among older Americans hospitalized for ischemic stroke was higher for blacks, while the 30-day case fatality following recurrent stroke remained lower for blacks.Study Supported by:AHA 14CRP20380256Disclosure: Dr. Albright has nothing to disclose. Dr. Huang has nothing to disclose. Dr. Blackburn has nothing to disclose. Dr. Howard has received personal compensation for activities with Bayer Healthcare. Dr. Howard has received research support from Amgen and Bayer Healthcare. Dr. Howard is a consultant to Abbott. Dr. Mullen has nothing to disclose. Dr. Bittne...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Albright, K., Huang, L., Blackburn, J., Howard, G., Mullen, M., Bittner, V., Muntner, P., Howard, V. Tags: Neuroepidemiology: Cerebrovascular Disease I Source Type: research

The Incidence Of Secondary Stroke Prevention Medication Following Hospitalization For Ischemic Stroke (P5.005)
CONCLUSIONS:The incidence of statins and ACE-I/ARB initiation following a stroke, among older adults discharged home was low (24-35%). Reported rates of side effects of either class of medications are not high enough to account for the low observed incidence. Better understanding of why beneficiaries are not receiving SSP, namely statins and ACE-I/ARBs, within 90 days of an ischemic stroke is critical to preventing recurrent stroke.Study Supported by:UnfundedDisclosure: Dr. Blackburn has nothing to disclose. Dr. Zhao has nothing to disclose. Dr. Kilgore has nothing to disclose. Dr. Albright has received research support fr...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Blackburn, J., Zhao, H., Kilgore, M., Albright, K. Tags: Cerebrovascular Disease and Interventional Neurology II Source Type: research

Analysis of 30 Day Unexpected Readmission Rates in Stroke Patients at an Academic Acute-care Hospital (P5.151)
CONCLUSIONS:SNFs accounted for the greatest percentage of unexpected stroke patient readmissions occurring within 30 days, while IR accounted for none. Main readmitting causes included cerebrovascular, cardiovascular, infections, and dehydration. 70[percnt] of readmissions were geriatric patients. Study Supported by: None.Disclosure: Dr. Kushner has nothing to disclose. Dr. Kelly has nothing to disclose. Dr. Morrison has nothing to disclose. Dr. Camfield has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Kushner, D., Kelly, E., Morrison, R., Camfield, K. Tags: Cerebrovascular Disease and Interventional Neurology: Quality Research and Initiatives Source Type: research

Getting to the Core of Stroke Care: Real Time Chart Review Improves Hospital Compliance with Core Measures (P6.269)
Conclusions:Real time chart review, utilization of a MQA, and alerting of providers is significantly more effective than a process utilizing retrospective chart review based on sampling and manual abstraction in increasing CM compliance. Implementation of these methods reduces CM deficiencies and leads to improved stroke care.Disclosure: Dr. Katsafanas has nothing to disclose. Dr. Furbeyre has nothing to disclose. Dr. Coppen has nothing to disclose. Dr. Hodges has nothing to disclose. Dr. Schnepel has nothing to disclose. Dr. Falk has nothing to disclose. Dr. Alonso has nothing to disclose. Dr. Tran has nothing to disclose...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Katsafanas, C., Furbeyre, J., Coppen, V., Hodges, W., Schnepel, L., Falk, D., Alonso, J., Tran, A., Northcut, M., Toback, A., Silliman, S. Tags: Cerebrovascular Disease Health Services Research Source Type: research

Risk of Ischemic Stroke in Patients with Atrial Flutter (S36.007)
Conclusions:Patients with AFL may face a lower risk of ischemic stroke than patients with AF.Disclosure: Dr. Alkawaz has nothing to disclose. Dr. Salehi Omran has nothing to disclose. Dr. Parikh has nothing to disclose. Dr. Elkind has received personal compensation in an editorial capacity for Neurology. Dr. Soliman has nothing to disclose. Dr. Kamel has received personal compensation for activities with Genentech as a speaker. Dr. Kamel has received personal compensation in an editorial capacity for Journal Watch Neurology.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Alkawaz, M., Omran, S. S., Parikh, N., Elkind, M., Soliman, E., Kamel, H. Tags: Cerebrovascular Disease and Interventional Neurology: Epidemiology Source Type: research

Factors Associated With 30-Day Readmission Rate Among Stroke Patients From 2009-2012 At Two Tertiary Level Hospitals In Metro Portland Area (P3.090)
CONCLUSIONS:Elderly patients with stroke with shorter length of stay who are discharged home are at the highest risk for getting readmitted within 30 days. These subgroups could be targeted for interventions in preventing 30 day readmission. These findings should be validated in larger studies.Disclosure: Dr. Kansara has nothing to disclose. Dr. Stuchiner has nothing to disclose. Dr. Baraban has nothing to disclose. Dr. Bhatt has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Kansara, A., Stuchiner, T., Baraban, E., Bhatt, A. Tags: Cerebrovascular Disease and Interventional Neurology: Clinical Management Source Type: research

Racial And Ethnic Disparities In Stroke. Declining Age At Time Of Stroke. Analysis Of The Nationwide Inpatient Sample 1988-2010 (S12.002)
CONCLUSIONS: In this longitudinal national sample age at time of stroke became younger for blacks and Hispanics, but not Caucasians. This has increased the disparity of age of onset between blacks and Caucasians. Over time the number of comorbidities have increased, perhaps due to upcoding by hospitals rather than worsening health status of the population.Disclosure: Dr. Costa has nothing to disclose. Dr. Dubinsky has received personal compensation for activities with Allergan Inc. Dr. Dubinsky has received research support from Allergan Inc., Medevation Pharmaceuticals, and from the National Institutes of Health.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Costa, C., Dubinsky, R. Tags: Cerebrovascular Disease and Interventional Neurology: Epidemiology and Risk Factors Source Type: research